Osteoporosis

 

Post Fracture Oversight Persists in Osteoporosis

September 25, 2020

In a review recently published in Current Osteoporosis Reports, Sarah French, M.D., a rheumatologist with the University of California at San Francisco, summarizes performance quality measures for osteoporosis using Centers for Medicare and Medicaid measures for pay-for-performance programs. In this interview, Dr. French shares with us her findings.

Here's Where We Fail (and Succeed) in Osteoporosis Care

September 18, 2020

Today, we talk with Dr. Sarah French, a rheumatologist with the University of California at San Francisco. Dr. French recently published a review in Current Osteoporosis Reports that addresses successes and failures in quality improvement initiatives in osteoporosis. Through the MIPS program, healthcare providers are required to select six quality measures. And while they may be performing well on osteoporosis screenings, their track record on osteoporosis management isn't fairing as well. Dr. French has identified this as an area for improvement. In this interview, she explains how.

Bisphosphonate Use Associated with Increased Fracture Risk

September 16, 2020

Bisphosphonate use, especially for more than five years, is associated with an increased risk of atypical femoral fractures, but this risk falls considerably after discontinuation, according to a Nationwide Danish an analysis and review presented on September 13 at the American Society for Bone and Mineral Research (ASBMR) annual meeting which was held virtually.

Teriparatide for Bone Formation in Hip Fractures

September 16, 2020

Teriparatide, a recombinant human parathyroid hormone analog [rhPTH(1-34)] approved for women and men with osteoporosis, has been shown to renew bone tissue in patients with femoral neck fractures of the hip, according to research presented at the American Society for Bone and Mineral Research (ASBMR) annual meeting which was held this week.

Zoledronate As Booster Drug in Fight Against Osteoporosis

September 14, 2020

Some evidence shows the combination of teriparatide and denosumab, followed by a single dose of zoledronate, may be an effective strategy in the long-term management of high-risk fragility fractures.

Abaloparatide Shown to Increase Bone Mineral Density

September 11, 2020

The osteoporosis treatment abaloparatide has been shown to increase bone mineral density of the lumbar spine, total hip and femoral neck bone in patients with osteoporosis who are at high risk for fracture, according to a study presented today at the American Society for Bone and Mineral Research annual meeting which is being held virtually through Tuesday.

Loss of Total Body Lean Mass Linked to Increase Risk of Fractures

September 07, 2020

Patients attempting to lose weight through dietary changes should be advised of the importance of maintaining their existing muscle mass and strength through exercise, so as not to increase their risk of fractures, Canadian researchers say.

Repeat BMD Testing Every Three Years May Hold Little Value

September 07, 2020

Postmenopausal women may not need a repeat bone mineral density test after three years to determine risk of osteoporotic fracture, a study finds.

Smoking Declines Precede Dip in Hip Fractures

September 03, 2020

Hip fractures in the United States and developed countries have been declining for over four decades. But why? Dr. Timothy Bhattacharyya, an orthopedic surgeon and head of Orthopedics Research for the Clinical Trials and Outcomes Branch of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, delved into the root cause of this phenomenon in a study published in July in JAMA Internal Medicine.

Treatment Adherence Still Difficult in Osteoporosis

August 18, 2020

Persistence and adherence to parenteral osteoporosis therapies are suboptimal and worsen with time, a study finds.

Quiz: Which RA drug has the least negative impact on bone mineral density?

August 17, 2020

Patients with rheumatoid arthritis are at increased risk for osteoporosis. This heightened risk of osteoporosis can be due to a combination of factors: inactivity due to the pain and loss of joint function associated with the disease, a direct the rheumatoid arthritis disease process, and their treatment for rheumatoid arthritis. In this quiz, test your knowledge on the risk of osteoporosis in rheumatoid arthritis and how it should be treated.

Bone Health ECHO Expands Osteoporosis Training for Physicians

August 17, 2020

TeleECHO educational programs for healthcare providers have successfully trained physicians and other healthcare providers to fulfill the unmet needs of patients without access to specialty care, particularly osteoporosis care. In this interview with Dr. Michael Lewiecki, he introduces us to Bone Health TeleECHO. He tells us how the program works, why it’s needed and how you can launch one in your state.

Two Osteoporosis Medications Shown to Be Equally Effective

August 17, 2020

Raloxifene is as effective as alendronate at preventing osteoporotic hip fractures in women, shows a new study.

Podcast: Are your patients well verse on vitamin D intake?

August 03, 2020

Managing vitamin D levels may not be as straightforward as it would seem. There are factors that should be considered that are not often communicated to patients. In today's edition of Overdrive, the Rheumatology Network podcast, we talk with Dr. Suzanne Jan de Beur of Johns Hopkins University School of Medicine. She serves as director of endocrinology at Johns Hopkins Bayview Medical Center and president-elect of the American Society for Bone and Mineral Research.

Osteoporosis Screening May Be Necessary for Younger Postmenopausal Women

July 23, 2020

Osteoporosis isn't unique to older women, according to a review published in JAMA. At-risk younger women should be screened as well. In this Q&A, Dr. Carolyn J. Crandall of UCLA discusses osteoporosis screening in younger postmenopausal women.

Vitamin D Exposure for Optimal Bone Health

July 22, 2020

Managing vitamin D levels may not be as straightforward as it would seem. There are factors that should be considered that are not often communicated to patients. In today's edition of Overdrive, the Rheumatology Network podcast, we talk with Dr. Suzanne Jan de Beur of Johns Hopkins University School of Medicine. She serves as director of endocrinology at Johns Hopkins Bayview Medical Center and president-elect of the American Society for Bone and Mineral Research.

Bone Density Report Is Normal but Fracture Suggests Otherwise

July 08, 2020

Patients with suspected osteoporotic fractures and normal DXA rarely have normal bone, shows a new study.

Study Disputes Association Between Inhaled Steroids and Osteoporosis

July 08, 2020

Inhaled corticosteroids for asthma or COPD do not increase the risk of major osteoporotic fractures in older women, new study shows.

Osteoporosis Treatment Under COVID-19

June 19, 2020

A steering committee of the American Society for Bone Mineral Research recently issued COVID-19 treatment guidelines for patients receiving osteoporosis treatments. In this interview, E. Michael Lewiecki, M.D., director of the New Mexico Clinical Research and Osteoporosis Center and a University of New Mexico program called Bone Health TeleECHO, shares his best practices for treating osteoporosis patients during the pandemic.

The Pros and Cons of DXA-What Are the Alternatives?

June 10, 2020

A wide range of techniques are used in research to assess bone density and quality, but dual-energy X-ray absorptiometry (DXA) is likely to remain the standard procedure used in clinical practice for the foreseeable future for most patients, predicts the co-author of a recent review of imaging-based techniques for assessing bone in rheumatology.